Home Banner 2 Dr Yutaka Niihara

Features

Clinical Trials

Enrollment for a Phase III clinical trial for L-glutamine for sickle cell disease began in early 2010 at various sites nationwide. Currently there are trial sites in Alabama, Louisiana, Georgia, Massachusetts, Maryland, California, and New York. The company anticipates completing enrollment for the Phase III trial in late 2012.

Continue reading...